📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MAIT cell activation augments adenovirus vector vaccine immunogenicity. (2021)

First Author: Provine NM

Attributed to: A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.aax8819

PubMed Identifier: 33510029

Publication URI: http://europepmc.org/abstract/MED/33510029

Type: Journal Article/Review

Volume: 371

Parent Publication: Science (New York, N.Y.)

Issue: 6528

ISSN: 0036-8075